Minnesota Oncology Hematology — Saint Paul, Minnesota

Minnesota Oncology Hematology is a clinical research site located in Saint Paul, Minnesota, United States 55102-2389.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Minnesota Oncology Hematology has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms.

Sponsors: Novartis Pharmaceuticals, CanariaBio Inc., Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Oncology Hematology?

Minnesota Oncology Hematology has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Oncology Hematology conducted?

Minnesota Oncology Hematology has 5 clinical trials on record, with 2 currently active. Their work covers Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms.

Is Minnesota Oncology Hematology accredited by Crixeo Health?

Yes — Minnesota Oncology Hematology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Minnesota Oncology Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.